The DOI matches its Crossref record; 66 of the 66 references it cites were found in a registry or an index.
Relative potency of proton-pump inhibitors—comparison of effects on intragastric pH
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Clinical Significance of the Cytochrome P450 2C19 Genetic Polymorphism
Desta, Z., Zhao, X., Shin, J.-G., & Flockhart, D. A. (2002) · Clinical Pharmacokinetics · doi:10.2165/00003088-200241120-00002 · Cited by 942
Kirchheiner, J., Nickchen, K., Bauer, M., Wong, M.-L., Licinio, J., Roots, I., & Brockmöller, J. (2004) · Molecular Psychiatry · doi:10.1038/sj.mp.4001494 · Cited by 724
Self-citationAppropriate Acid Suppression for the Management of Gastro-Oesophageal Reflux Disease
Bell, N. J. V., Burget, D., Howden, C. W., Wilkinson, J., & Hunt, R. H. (1992) · Digestion · doi:10.1159/000200917 · Cited by 542
Miner, P. (2003) · The American Journal of Gastroenterology · doi:10.1016/j.amjgastroenterol.2003.09.053 · Cited by 442
Kirchheiner, J., Brøsen, K., Dahl, M. L., Gram, L. F., Kasper, S., Roots, I., Sjöqvist, F., Spina, E., & Brockmöller, J. (2001) · Acta Psychiatrica Scandinavica · doi:10.1034/j.1600-0447.2001.00299.x · Cited by 422
Self-citationTreatment of Reflux Oesophagitis
(1988) · InPharma · doi:10.1007/bf03308057 · Cited by 390
Is there an optimal degree of acid suppression for healing of duodenal ulcers?
Burget, D. W., Chiverton, S. G., & Hunt, R. H. (1990) · Gastroenterology · doi:10.1016/0016-5085(90)91015-x · Cited by 340
Stedman, C. A. M., & Barclay, M. L. (2000) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.2000.00788.x · Cited by 317
Lind, Rydberg, Kylebäck, Jonsson, Andersson, Hasselgren, Holmberg, & Röhss (2000) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.2000.00813.x · Cited by 278
Influence of CYP2C19 Pharmacogenetic Polymorphism on Proton Pump Inhibitor-based Therapies
Furuta, T., Shirai, N., Sugimoto, M., Nakamura, A., Hishida, A., & Ishizaki, T. (2005) · Drug Metabolism and Pharmacokinetics · doi:10.2133/dmpk.20.153 · Cited by 257
Armstrong, D., Marshall, J. K., Chiba, N., Enns, R., Fallone, C. A., Fass, R., Hollingworth, R., Hunt, R. H., Kahrilas, P. J., Mayrand, S., et al. (2005) · Canadian Journal of Gastroenterology · doi:10.1155/2005/836030 · Cited by 238
Shirai, N., Furuta, T., Moriyama, Y., Okochi, H., Kobayashi, K., Takashima, M., Xiao, F., Kosuge, K., Nakagawa, K., Hanai, H., et al. (2001) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.2001.01108.x · Cited by 221
Gralnek, I. M., Dulai, G. S., Fennerty, M. B., & Spiegel, B. M. R. (2006) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2006.09.013 · Cited by 198
Effect of Helicobacter pylori status on intragastric pH during treatment with omeprazole.
Verdú, E. F., Armstrong, D., Fraser, R., Viani, F., Idström, J. P., Cederberg, C., & Blum, A. L. (1995) · Gut · doi:10.1136/gut.36.4.539 · Cited by 188
Nocturnal gastric acidity and acid breakthrough on different regimens of omeprazole 40 mg daily
Hatlebakk, Katz, Kuo, & Castell (1998) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.1998.00426.x · Cited by 181
Prichard, P. J., Yeomans, N. D., Mihaly, G. W., Jones, D. B., Buckle, P. J., Smallwood, R. A., & Louis, W. J. (1985) · Gastroenterology · doi:10.1016/s0016-5085(85)80133-5 · Cited by 180
Role of gastric acid suppression in the treatment of gastro-oesophageal reflux disease.
Bell, N. J., & Hunt, R. H. (1992) · Gut · doi:10.1136/gut.33.1.118 · Cited by 180
The CYP2C19 Enzyme Polymorphism
Wedlund, P. J. (2000) · Pharmacology · doi:10.1159/000028398 · Cited by 175
Williams, Sercombe, Hamilton, & Pounder (1998) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.1998.00418.x · Cited by 168
CYP2C19 Polymorphism and Proton Pump Inhibitors
Klotz, U., Schwab, M., & Treiber, G. (2004) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/j.1600-0773.2004.pto950102.x · Cited by 166
Self-citationhss, K. R., Lind, T., & Wilder‐Smith, C. H. (2004) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-004-0804-6 · Cited by 153
Acid inhibition on the first day of dosing: comparison of four proton pump inhibitors
Pantoflickova, D., Dorta, G. O., Ravic, M., Jornod, P., & Blum, A. L. (2003) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.2003.01496.x · Cited by 139
Caro, J. J. (2001) · Clinical Therapeutics · doi:10.1016/s0149-2918(01)80087-4 · Cited by 133
Klotz, U. E. (2006) · International Journal of Clinical Pharmacology and Therapeutics · doi:10.5414/cpp44297 · Cited by 132
Self-citationHuang, J.-Q., & Hunt, R. H. (2001) · Best Practice & Research Clinical Gastroenterology · doi:10.1053/bega.2001.0184 · Cited by 127
CYP2C19 Genotype and Pharmacokinetics of Three Proton Pump Inhibitors in Healthy Subjects
Sakai, T., Aoyama, N., Kita, T., Sakaeda, T., Nishiguchi, K., Nishitora, Y., Hohda, T., Shirasaka, D., Tamura, T., Tanigawara, Y., et al. (2001) · Pharmaceutical Research · doi:10.1023/a:1011035007591 · Cited by 122
Hunt, R. H. (1995) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.1995.tb00777.x · Cited by 120
Pharmacodynamic effects and kinetic disposition of rabeprazole in relation to CYP2C19 genotypes
Horai, Y., Kimura, M., Furuie, H., Matsuguma, K., Irie, S., Koga, Y., Nagahama, T., Murakami, M., Matsui, T., Yao, T., et al. (2001) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.2001.00980.x · Cited by 118
Helicobacter pylori infection potentiates the inhibition of gastric acid secretion by omeprazole
Gillen, D., Wirz, A. A., Neithercut, W. D., Ardill, J. E. S., & MCCOLL, K. E. L. (1999) · Gut · doi:10.1136/gut.44.4.468 · Cited by 117
Padol, S., Yuan, Y., Thabane, M. E., Padol, I. T., & Hunt, R. H. (2007) · International Journal of Clinical Pharmacology and Therapeutics · doi:10.5414/cpp45188 · Cited by 105
The relationship between suppression of acidity and gastric ulcer healing rates
Howden, C. W., & Hunt, R. H. (1990) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.1990.tb00445.x · Cited by 100
Clarke, M. J. (2000) · The Lancet · doi:10.1016/s0140-6736(05)72172-3 · Cited by 100
Meta‐analysis: comparing the efficacy of proton pump inhibitors in short‐term use
Klok, R. M., Postma, M. J., van Hout, B. A., & Brouwers, J. R. B. J. (2003) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.2003.01562.x · Cited by 98
The Effects of Oral Doses of Lansoprazole and Omeprazole on Gastric pH
Tolman, K. G., Sanders, S. W., Buchi, K. N., Karol, M. D., Jennings, D. E., & Ringham, G. L. (1997) · Journal of Clinical Gastroenterology · doi:10.1097/00004836-199703000-00003 · Cited by 95
Katz, P. O., Koch, F. K., BALLARD, E. D., et al. (2007) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2006.03191.x · Cited by 93
Hunfeld, N., Mathôt, R. A. A., Touw, D. J., van Schaik, R. H., Mulder, P. G. H., Franck, P., Kuipers, E. J., & Geus, W. P. (2008) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2007.03094.x · Cited by 93
Sagar, M., Tybring, G., Dahl, M., Bertilsson, L., & Seensalu, R. (2000) · Gastroenterology · doi:10.1053/gast.2000.16515 · Cited by 86
Hartmann, M., Theiss, U., Huber, R., Lühmann, R., Bliesath, H., Wurst, W., & Lücker, P. W. (1996) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.0953-0673.1996.00359.x · Cited by 82
Katz, P. O., Castell, D. O., Chen, Y., Andersson, T., & Sostek, M. B. (2004) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2004.02079.x · Cited by 72
Castell, D. O., Bagin, R. G., Goldlust, B., Major, J., & Hepburn, B. (2005) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2005.02513.x · Cited by 70
Equipotent inhibition of gastric acid secretion by equal doses of oral or intravenous pantoprazole
Hartmann, Ehrlich, Fuder, Lühmann, Emeklibas, Timmer, Wurst, & Lücker (1998) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.1998.00406.x · Cited by 56
ROBINSON, M. G., Maton, P. N., Rodriguez, S., Greenwood, B., & Humphries, T. J. (1997) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.1997.00244.x · Cited by 55
The effects of lansoprazole, a new H+,K+‐ATPase inhibitor, on gastric pH and serum gastrin
Sanders, S. W., Tolman, K. G., GRESKI, P. A., Jennings, D. E., Hoyos, P. A., & Page, J. G. (1992) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.1992.tb00057.x · Cited by 51
Koop, H., Kuly, S., Flüg, M., Eissele, R., Mönnikes, H., Rose, K., Lühmann, R., Schneider, A., Fischer, R., & Arnold, R. (1996) · PubMed · Cited by 48
Williams, Blanshard, Millson, Sercombe, & Pounder (2000) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.2000.00772.x · Cited by 45
Freston, J. W., Chiu, Y., Pan, W., Lukasik, N. L., & Täubel, J. (2001) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2001.03939.x · Cited by 42
Wilder‐Smith, C. H., Rohss, K. M., Nilsson-Pieschl, C., Junghard, O., & Nyman, L. (2003) · Digestion · doi:10.1159/000075697 · Cited by 40
Galmiche, J., Sacher‐Huvelin, S., Varannes, S. B. D., Vavasseur, F., Taccoen, A., Fiorentini, P., & Homerin, M. (2005) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2005.02381.x · Cited by 39
Dose–response relationship of lansoprazole to gastric acid antisecretory effects
Blum, Hunt, Kidd, Shi, Jennings, & Greski‐Rose (1998) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.1998.00306.x · Cited by 36
Miehlke, S., Madisch, A., Kirsch, C., Lindner, F., Kuhlisch, E., Laass, M. W., Knoth, H., Morgner, A., & Labenz, J. (2005) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2005.02432.x · Cited by 35
Armstrong, D., James, C., Camacho, F., Chen, Y., Horbay, G. L. A., TEIXEIRA, B., & Husein-Bhabha, F. A. (2006) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2006.03160.x · Cited by 35
Florent, C., & Forestier, S. (1997) · European Journal of Gastroenterology & Hepatology · doi:10.1097/00042737-199702000-00017 · Cited by 34
Johnson, D. A., STACY, T., Ryan, M. J., Wootton, T., Willis, J., Hornbuckle, K., Brooks, W. D., & DOVIAK, M. J. (2005) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2005.02534.x · Cited by 34
Ohning, Barbuti, Kovács, Sytnik, Humphries, & Walsh (2000) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.2000.00774.x · Cited by 34
Armbrecht, U., ABUCAR, A., Hameeteman, W. M., Schneider, A., & Stockbrügger, R. W. (1997) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.1997.00195.x · Cited by 32
Dose‐dependent control of intragastric pH by pantoprazole, 10, 20 or 40 mg, in healthy volunteers
Tutuian, R. I., Katz, P. O., Bochenek, W. J., & Castell, D. O. (2002) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.2002.01232.x · Cited by 32
Dammann, H. G., Mühlen, A. V. Z., Balks, H. J., DAMASCHKE, A., STEINHOFF, J., HENNIG, U., SCHWARZ, J. A., & Fuchs, W. A. (1993) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.1993.tb00089.x · Cited by 31
Effect of pantoprazole on 24‐h intragastric pH and serum gastrin in humans.
Londong, W. (1994) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.1994.tb00239.x · Cited by 30
Goldstein, J. L., Miner, P. B., Schlesinger, P. K., Liu, S., & Silberg, D. G. (2006) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2006.02867.x · Cited by 29
Norris, V., Baisley, K. J., DUNN, K., Warrington, S., & Morocutti, A. (2007) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2006.03221.x · Cited by 27
Houben, G., Hooi, J. D., Hameeteman, W. M., & Stockbrügger, R. W. (1995) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.1995.tb00434.x · Cited by 26
Effects of oral pantoprazole on 24‐hour intragastric acidity and plasma gastrin profiles
Hannan, A. J., Weil, J., Broom, C., & Walt, R. P. (1992) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.1992.tb00058.x · Cited by 25
Timmer, W., Ripke, H., Kleist, P., Ehrlich, A., Wieckhorst, G., Lücker, P. W., & FUDER, H. (1995) · PubMed · Cited by 22
Control of intragastric pH with omeprazole 20 mg, omeprazole 40 mg and lansoprazole 30 mg
Katz, P. O., Xue, S., & Castell, D. O. (2001) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.2001.00967.x · Cited by 20
Lin, C., Yang, J., Uang, Y., Chern, H., & Wang, T. (2003) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.23.6.711.32177 · Cited by 18
Katz, P. O. (2006) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2006.02801.x · Cited by 15
Cited by
ACG Clinical Guideline for the Diagnosis and Management of Gastroesophageal Reflux Disease
Katz, P. O., Dunbar, K. B., Schnoll-Sussman, F. H., Greer, K. B., Yadlapati, R., & Spechler, S. J. (2022) · American Journal of Gastroenterology · doi:10.14309/ajg.0000000000001538 · Cited by 1,038
for the SIF-AIGO-FIMMG Group, Scarpignato, C., on behalf of the Italian Society of Pharmacology, T. I. A. O. H. G., Gatta, L., Zullo, A., & Blandizzi, C. (2016) · BMC Medicine · doi:10.1186/s12916-016-0718-z · Cited by 469
Nyssen, O. P., Bordin, D., Tepes, B., Pérez-Aisa, Á., Vaira, D., Caldas, M., Bujanda, L., Castro-Fernandez, M., Lerang, F., Leja, M., et al. (2021) · Gut · doi:10.1136/gutjnl-2020-321372 · Cited by 264
Metadata
- Authors
- Kirchheiner, J., Glatt, S., Fuhr, U., Klotz, U., Meineke, I., Seufferlein, T., & Brockmöller, J.
- Venue
- European Journal of Clinical Pharmacology
- Published
- 2008-10-17
- Volume
- 65
- Issue
- 1
- Pages
- 19-31
- ISSN
- 0031-6970 (ISSN-L)
- 1432-1041
- OpenAlex
- W2156899992
- Cited by
- 277
- References
- 66
- FWCI
- 7.22
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.